Healthcare & Life Sciences

OmnilinX Therapeutics AG

Switzerland
Sign in to unlock

About

OmnilinX Therapeutics AG is a biotechnology company focused on the development of therapeutics that modulate nuclear receptors to treat metabolic and inflammatory diseases.

Explore OmnilinX Therapeutics AG's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing